The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis
Abstract
Objective To determine whether all-trans-retinoic acid (ATRA) improves the destruction of joints and the effect of cytokines on DBA/1J mice with collagen-induced arthritis (CIA).Methods Starting from the time of type II collagen injection, DBA/1J mice were injected intraperitoneally with PBS or 0.5 mg of ATRA 3 times per week for 35 days. The effects of treatment were monitored by determining arthritis and histological scores and measuring cellular proliferation, production of cytokines (IL-2, IL-10, IL-12, IL-6, IFN-gamma, and TNF-alpha) and IgG, and the expression of mRNAs for inducible nitric oxide synthase (iNOS), monocyte chemoattractant protein-1 (MCP-1), and CXCR3.Results The arthritis score and incidence of arthritis were lower in the mice treated with ATRA than in those treated with PBS. Histopathologic evidence of joint damage was 34% lower, and the infiltrations of macrophages were reduced in the mice treated with ATRA compared with those treated with PBS. Type II collagen- and ConA-stimulated proliferation of spleen cells, the production of cytokines (IL-6, IL-12, and TNF-alpha), the serum levels of total IgG and IgG1 anti-collagen antibodies, and the expression of mRNAs for MCP-1 were significantly reduced in the mice treated with ATRA than in those treated with PBS.Conclusion ATRA improved the clinical course and reduced the production of inflammatory cytokines, immunoglobulin, and chemokines in murine CIA. These data suggest that ATRA might be also effective for the treatment of inflammatory arthritis like human rheumatoid arthritis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“retinoids have been described as potent anti-inflammatory and therefore protective in pathologies such as chronic obstructive pulmonary disease74, rheumatoid arthritis122, psoriasis123, and inflammatory bowel disease124.”
From Advances and challenges in retinoid delivery systems in regenerative and therapeutic medicine (2020) · cites this paper as [122]
Citations
Cites
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,507
Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
Huang, M., Ye, Y., Chen, S. R., Chai, J., Lu, J., Zhoa, L., Gu, L.-J., & Wang, Z.-Y. (1988) · Blood · doi:10.1182/blood.v72.2.567.567 · Cited by 2,445
Van Snick, J. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.001345 · Cited by 1,890
Autoimmunity to type II collagen an experimental model of arthritis.
Trentham, D. E., Townes, A. S., & Kang, A. H. (1977) · The Journal of Experimental Medicine · doi:10.1084/jem.146.3.857 · Cited by 1,608
Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes
Sallusto, F., Lenig, D., Mackay, C. R., & Lanzavecchia, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.6.875 · Cited by 1,535
Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant.
Carr, M. W., Roth, S. J., Luther, E., Rose, S. S., & Springer, T. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3652 · Cited by 1,198
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 991
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81109-5 · Cited by 978
Houssiau, F. A., Devogelaer, J., Damme, J. V., Deuxchaisnes, C. N. D., & Snick, J. V. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310614 · Cited by 847
Ishiyama, M., Tominaga, H., Shiga, M., Sasamoto, K., Ohkura, Y., & Ueno, K. (1996) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.19.1518 · Cited by 737
Flagged first, then by citations
Research works printed but not linked: 1
- Orfanos, 1983, Evidence for antiinflammatory activities for oral and synthetic retinoids, Br. J. Dermatol., 25, 55
Cited by
Sorted by citations
Items 101–106 of 106
Cai, Q.-Y., Yulin, L. I., Fan, L. Y. U., Mingming, Z. H. O. U., Lu, K., Tang, X., Ren, D., Bao, Q., Wang, D., & Li, Y. (2020) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.66.300
Retinoic acid in mucosal immune-regulation
Mucida, D., & Cheroutre, H. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8681-8_5
Fosang, A., & Rogerson, F. M. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.9567956.11281055
Zheng, X., Ke, X., Gao, J., Zheng, Z., & Zhu, P. (2025) · Clinical Rheumatology · doi:10.1007/s10067-025-07482-0
Vitamin A is necessary for acquisition, but not for expression or progression, of CNS autoimmunityPreprint
Horai, R., Zhou, R., Bing, S. J., Wloka, K., Jittyasothorn, Y., Duncan, T. E., Mattapallil, M. J., Silver, P. B., Chan, C., & Caspi, R. R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.18.654726
Wright, N. S., Bhashyam, P., Seo, L., Wu, T., McGurk, A. I., Ocasio‐Rivera, M., D’Amato, A. R., Fowell, D. J., & Wang, Y. (2026) · RSC Pharmaceutics · doi:10.1039/d5pm00233h
Metadata
- Authors
- Nozaki, Y., Yamagata, T., Sugiyama, M., Ikoma, S., Kinoshita, K., & Funauchi, M.
- Affiliations
- Kindai University (JP)
- Corresponding author
- Kinoshita, Koji
- Venue
- Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 119
- Issue
- 3
- Pages
- 272-279
- ISSN
- 1521-6616 (ISSN-L)
- OpenAlex
- W1964207984
- Cited by
- 106
- References
- 37
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 3 · 2021: 5 · 2020: 6 · 2019: 6 · 2018: 4 · 2017: 4 · 2016: 3 · 2015: 4 · 2014: 5 · 2013: 8 · 2012: 12
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Health Sciences › Medicine › Hematology › Autoimmune and Inflammatory Disorders Research
- Keywords
- all-trans retinoic acid, inflammatory arthritis, collagen-induced arthritis, rheumatoid arthritis, anti-inflammatory activity, cytokines, type II collagen, anti-collagen antibodies, MCP-1, CXCR3, inducible nitric oxide synthase, macrophage infiltration, immunosuppression
- MeSH terms
- Animals, Anti-Inflammatory Agents, Arthritis, Experimental, Collagen, Gene Expression Regulation, Immunoglobulin G, Joints, Male, Mice, Inbred DBA, RNA, Messenger, Spleen, Tretinoin, Cytokines, Chemokine CCL2, Receptors, Chemokine, Cell Proliferation, Mice, Nitric Oxide Synthase Type II, Receptors, CXCR3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
